Clinical Trial

Safety and Pharmacokinetics of Rescue Liposome in Healthy Adults

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This is a Phase 1 study to assess the safety and tolerability of the liposomal product in healthy participants.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-21.
Trial Details
NCT Number NCT07375498
Lead Sponsor Cristália Produtos Químicos Farmacêuticos Ltda.
Conditions Healthy Adult, Overdose Antidote
Enrollment 12 participants
Start Date 2026-08-20
Primary Completion 2026-12-20 (estimated)
Study Completion 2027-02-20 (estimated)
Updated on ClinicalTrials.gov 2026-02-04